Short answer
Aquestive Therapeutics, Inc. (AQST) filed an 8-K current report with the SEC on October 19, 2026 reporting Item 5.03 (Amendments to Articles of Incorporation or Bylaws). Board-adopted bylaws effective October 15, 2026, superseding prior bylaws.
Aquestive Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.03 · Amendments to Articles of Incorporation or Bylaws
- Board-adopted bylaws effective October 15, 2026, superseding prior bylaws
- Reduced disclosure requirements for stockholder board nominations
- Removed certain “acting in concert” relationship disclosures involving nominees and associated persons
- Potentially lowers procedural burden for shareholders proposing director candidates
- Exhibit 3.1 contains controlling amended-bylaw language
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Aquestive Therapeutics, Inc. 8-K filings
Get the next AQST 8-K as it lands
Follow AQST for push alerts, or ask the research agent what this filing means.